New chemical and biological entities approved by the Therapeutic Goods Administration, January 1, 2005 to May 7, 2024
Access status:
Open Access
Type
DatasetAbstract
This dataset includes information on drug approvals by the Australian Therapeutic Goods Administration (TGA) from 2005 to May 2024. Generic, brand name, indication, approval pathway (when applicable), and date of approval are included. In addition, therapeutic ratings from the Patented Medicines Prices Review Board (PMPRB, Canada), Prescrire, Haute Autorité de Santé (HAS, France), and the Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG, Germany), and Pharmaceutical Benefits Schedule (PBS) listing status have been included.This dataset includes information on drug approvals by the Australian Therapeutic Goods Administration (TGA) from 2005 to May 2024. Generic, brand name, indication, approval pathway (when applicable), and date of approval are included. In addition, therapeutic ratings from the Patented Medicines Prices Review Board (PMPRB, Canada), Prescrire, Haute Autorité de Santé (HAS, France), and the Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG, Germany), and Pharmaceutical Benefits Schedule (PBS) listing status have been included.
See less
See less
Date
2024-12-02Licence
Creative Commons Attribution-NonCommercial 4.0Faculty/School
Faculty of Health, School of Health Policy and Management, York UniversityFaculty of Medicine and Health, School of Pharmacy, the University of Sydney
Share